What is the VEGF test?
This test measures the amount of vascular endothelial growth factor (VEGF) in your blood. VEGF is a substance that helps encourage the growth of new blood vessels. Your body makes more VEGF in certain cases. For instance, if your tissues aren't getting enough oxygen, they may make more VEGF so that new blood vessels grow to bring in more oxygen. Your lungs contain VEGF because good blood flow is vital there.
But VEGF also plays a role in cancer growth. Cancers need an ample blood supply. As a tumor grows larger, its cells need more oxygen from the blood. The cancer encourages new blood vessels to grow to supply it with more blood and oxygen. Most tumors show higher levels of VEGF. Sometimes higher levels mean a lower chance of survival. In addition, VEGF may be important in the spread of cancer to other places within your body. Certain cancer treatments target VEGF. This test may be used to tell how well the treatments are working.
VEGF can also promote "leakiness" of blood vessels. This can lead to swelling in surrounding areas. This can be especially harmful during brain cancer because it can increase pressure within the skull and may lead to brain damage. Leaking blood vessels in the eye causing problems is also seen in age-related macular degeneration and eye changes from diabetes.
Normal concentrations of VEGF do not exclude the diagnosis of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome.
The Vascular Endothelial Growth Factor (VEGF) test is useful for:
Evaluation of patients with suspected POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome, particularly in differentiating from other forms of polyneuropathy and monoclonal plasma cell disorders. Monitoring response to treatment in patients with a known diagnosis of POEMS syndrome.
More about VEGF:
VEGF stands for Vascular Endothelial Growth Factor. VEGF is a growth factor that promotes the growth of new blood vessels. The body makes VEGF in response to low oxygen levels, also known as hypoxia. Thus, when tissues are receiving too little oxygen rich blood flow, VEGF is produced to provide a better blood supply to the tissues. VEGF also increases the permeability or leakiness of blood vessels. In fact, one form of VEGF, VEGF-A was once known as vascular permeability factor. VEGF plays a role in cell metabolism, bone formation, and blood cell creation (hematopoiesis). Unfortunately, cancer cells also produce VEGF to help improve their own blood flow. Interestingly, cancer treatments have been developed to block the action of VEGF to starve cancerous tumors of blood flow.
VEGF is a prototype angiogenic factor, but recent evidence indicates that this growth factor also has direct effects on neural cells. Abnormal regulation of VEGF expression has now been implicated in several neurodegenerative disorders, including motoneuron degeneration.
References:
Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, Moldovan IM, Roman AL, Mihu CM. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467. PMID: 30173249.
Storkebaum E, Carmeliet P. VEGF: a critical player in neurodegeneration. J Clin Invest. 2004 Jan;113(1):14-8. doi: 10.1172/JCI20682. PMID: 14702101; PMCID: PMC300888.
Mateo I, Llorca J, Infante J, Rodríguez-Rodríguez E, Fernández-Viadero C, Peña N, Berciano J, Combarros O. Low serum VEGF levels are associated with Alzheimer's disease. Acta Neurol Scand. 2007 Jul;116(1):56-8. doi: 10.1111/j.1600-0404.2006.00775.x. PMID: 17587256.
Isung, J., Aeinehband, S., Mobarrez, F. et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2, e196 (2012). https://doi.org/10.1038/tp.2012.123
Isung J, Mobarrez F, Nordström P, Asberg M, Jokinen J. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry. 2012 Sep;13(6):468-73. doi: 10.3109/15622975.2011.624549. Epub 2011 Nov 18. PMID: 22098148.
Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003 Aug;34(4):383-94. doi: 10.1038/ng1211. PMID: 12847526.
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996 Apr 4;380(6573):435-9. doi: 10.1038/380435a0. PMID: 8602241.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.